KATRD
LOGIN
- KATRD 2021 International Conference
-
November 7(Thu)-8(Fri), 2020 Lotte Hotel World, Seoul, Kore
Program in Detail
한국어 진행 강의입니다.
|
[Symposium 07] Lung Cancer 1 - New Applicable Biomarkers in Lung Cancer |
15:10-16:30 |
||
|---|---|---|---|
| Chair | |||
| 10:30-11:00 | SY 7-1 |
Navigating the Evolving NSCLC 1L Treatment Landscape with a Focus on Nivolumab + Ipilimumab
|
|
| 11:00-11:30 | SY 7-2 |
Current Achievement and Future Perspective of Genome Profiling by Liquid Biopsy
|
|
| 11:30-12:00 | SY 7-3 |
Imaging Biomarkers in Lung Cancer
|
|
|
[Luncheon Symposium 03] Lung Cancer 
|
11:00-12:00 |
||
| Chair | |||
| 12:00-12:30 | LS 3 |
Transform Treatment Strategy for EGFRm NSCLC Patients from Early to Advanced Stage
|
|
|
[Symposium 08] Lung Cancer 2 - Additional Treatment: Worthwhile and When |
15:10-16:00 |
||
| Chair | |||
| 13:30-14:00 | SY 8-1 |
Adjuvant Chemotherapy of Completely Resected Stage 1 Non-Small Cell Lung Cancer
|
|
| 14:00-14:30 | SY 8-2 |
Abscopal Effect of Radiotherapy Combined with Immune Checkpoint Inhibitors
|
|
| 14:30-15:00 | SY 8-3 |
Salvage Surgery for Non-Small Cell Lung Cancer After Tyrosine Kinase Inhibitor Treatment
|
|
|
[Symposium 09] Lung Cancer 3 - Beyond Standard Treatment |
08:00-08:50 |
||
| Chair | |||
| 15:30-16:00 | SY 9-1 |
The Emerging Therapeutic Landscape of ALK TKIs in Advanced NSCLC
|
|
| 16:00-16:30 | SY 9-2 |
Immune Checkpoint Inhibitors in NSCLC with Driver Mutations
|
|
| 16:30-17:00 | SY 9-3 |
Management of Brain Metastasis Considering Molecular Profiling
|
|